Clinical Trial Update: RETeval All Comers Trial (REACT) [NA]

View source ↗

Summary

The REACT trial evaluating RETeval in retinal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Disease

Snippet

Sponsor: LKC Technologies, Inc. | Conditions: Retinal Disease, Electroretinogram | NA | Status: COMPLETED